Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 25, 2022
Real-life experiences with bulevirtide for the treatment of hepatitis delta-48 weeks data from a German centre
Caroline Zöllner, Jörg Hofmann, Katrin Lutz, et al.
European Journal of Gastroenterology & Hepatology
|
August 24, 2016
High prevalence of anti-hepatitis E virus antibodies in outpatients with chronic liver disease in a university medical center in Germany
Marten Schulz, Daniel Beha, Kristina Plehm, et al.
Health Policy and Planning
|
January 28, 2014
Insecticide-treated mosquito nets in rural Burkina Faso: assessment of coverage and equity in the wake of a universal distribution campaign
Caroline Zöllner, Manuela De Allegri, Valérie R Louis, et al.
European Journal of Gastroenterology & Hepatology
|
January 17, 2017
Performance characterization of a novel electronic number connection test to detect minimal hepatic encephalopathy in cirrhotic patients
Tilo Wuensch, Darius Ferenc Ruether, Caroline Zöllner, et al.
Zeitschrift Fur Gastroenterologie
|
September 20, 2023
Percutaneous drainage and combined praziquantel-albendazole therapy: a novel approach for the treatment of simple echinococcal liver cysts
Joachim Richter, Andreas K Lindner, Dominik Geisel, et al.
Hepatology Communications
|
April 1, 2026
Second-line tacrolimus and mycophenolate mofetil in difficult-to-treat autoimmune hepatitis
Alena Laschtowitz, Clara Vom Endt, Martin Kluge, et al.
The Lancet. Infectious Diseases
|
December 29, 2016
Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study
Katja Deterding, Christoph D Spinner, Eckart Schott, et al.
JHEP Reports : Innovation in Hepatology
|
April 7, 2023
Treating hepatitis D with bulevirtide - Real-world experience from 114 patients
Christopher Dietz-Fricke, Frank Tacke, Caroline Zöllner, et al.
Journal of Hepatology
|
January 10, 2025
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis
Elisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 25, 2022
Real-life experiences with bulevirtide for the treatment of hepatitis delta-48 weeks data from a German centre
Caroline Zöllner, Jörg Hofmann, Katrin Lutz, et al.
European Journal of Gastroenterology & Hepatology
|
August 24, 2016
High prevalence of anti-hepatitis E virus antibodies in outpatients with chronic liver disease in a university medical center in Germany
Marten Schulz, Daniel Beha, Kristina Plehm, et al.
Health Policy and Planning
|
January 28, 2014
Insecticide-treated mosquito nets in rural Burkina Faso: assessment of coverage and equity in the wake of a universal distribution campaign
Caroline Zöllner, Manuela De Allegri, Valérie R Louis, et al.
European Journal of Gastroenterology & Hepatology
|
January 17, 2017
Performance characterization of a novel electronic number connection test to detect minimal hepatic encephalopathy in cirrhotic patients
Tilo Wuensch, Darius Ferenc Ruether, Caroline Zöllner, et al.
Zeitschrift Fur Gastroenterologie
|
September 20, 2023
Percutaneous drainage and combined praziquantel-albendazole therapy: a novel approach for the treatment of simple echinococcal liver cysts
Joachim Richter, Andreas K Lindner, Dominik Geisel, et al.
Hepatology Communications
|
April 1, 2026
Second-line tacrolimus and mycophenolate mofetil in difficult-to-treat autoimmune hepatitis
Alena Laschtowitz, Clara Vom Endt, Martin Kluge, et al.
The Lancet. Infectious Diseases
|
December 29, 2016
Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study
Katja Deterding, Christoph D Spinner, Eckart Schott, et al.
JHEP Reports : Innovation in Hepatology
|
April 7, 2023
Treating hepatitis D with bulevirtide - Real-world experience from 114 patients
Christopher Dietz-Fricke, Frank Tacke, Caroline Zöllner, et al.
Journal of Hepatology
|
January 10, 2025
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis
Elisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, et al.
Page
of 1